Inner Mongolia Furui Medical Science Co., Ltd. (SHE:300049)

China flag China · Delayed Price · Currency is CNY
40.25
-0.82 (-2.00%)
Jun 18, 2026, 3:04 PM CST
Market Cap10.63B +33.6%
Revenue (ttm)1.63B +19.8%
Net Income157.25M +58.5%
EPS0.59 +56.1%
Shares Out 263.99M
PE Ratio68.30
Forward PE36.59
Dividend0.02 (0.04%)
Ex-Dividend Daten/a
Volume6,348,124
Open42.64
Previous Close41.07
Day's Range40.19 - 42.64
52-Week Range30.25 - 90.68
Beta-0.43
AnalystsStrong Buy
Price Target70.00 (+73.91%)
Earnings DateAug 26, 2026

About SHE:300049

Inner Mongolia Furui Medical Science Co., Ltd. engages in the production and sale of pharmaceutical drugs in China and internationally. The company also engages in the research and development and sales of diagnostic equipment and related medical services. It offers FibroScan series of liver fibrosis diagnostic instruments; FibroMeter series of blood test analysis tools for evaluating chronic liver disease; and FibroView data management software. It provides digital health management services; compound turtle shell softening liver tablets; and ... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1998
Employees 946
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300049
Full Company Profile

Financial Performance

In 2025, SHE:300049's revenue was 1.60 billion, an increase of 18.26% compared to the previous year's 1.35 billion. Earnings were 154.09 million, an increase of 36.02%.

Financial Statements